{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:13:40Z","timestamp":1789992820548,"version":"4.0.1"},"reference-count":225,"publisher":"Walter de Gruyter GmbH","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Guillain\u2013Barr\u00e9 syndrome (GBS) is an acute inflammatory polyradiculoneuropathy; a disease involving the peripheral nervous system which is the most common cause of acute flaccid paralysis worldwide. So far, it is still lack of a comprehensive overview and understanding of the national epidemiological, clinical characteristics, and the risk factors of GBS in China, as well as differences between China and other countries and regions in these respects. With the global outbreak of the coronavirus disease 2019 (COVID-19), an epidemiological or phenotypic association between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and GBS has attracted great attention. In this review, we outlined the current clinical data of GBS in China by retrieving literature, extracting and synthesizing the data of GBS in China from 2010 to 2021. Besides, we compared the characteristics of epidemiology, preceding events and clinical profiles of GBS between China and other countries and regions. Furthermore, in addition to conventional intravenous immunoglobulin (IVIG) and plasma exchange (PE) therapy, the potential therapeutic effects with novel medications in GBS, such as complement inhibitors, etc., have become the research focus in treatments. We found that epidemiological and clinical findings of GBS in\u00a0China are approximately consistent with those in the International GBS Outcome Study (IGOS) cohort. We provided an overall picture of the present clinical status of GBS in China and summarized the global research progress of GBS, aiming to further understand the characteristics of GBS and improve the future work of GBS worldwide, especially in countries with the middle and low incomes.<\/jats:p>","DOI":"10.1515\/revneuro-2023-0024","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T15:21:19Z","timestamp":1683300079000},"page":"869-897","source":"Crossref","is-referenced-by-count":9,"title":["Current status of Guillain\u2013Barr\u00e9 syndrome (GBS) in China: a 10-year comprehensive overview"],"prefix":"10.1515","volume":"34","author":[{"given":"Yanna","family":"Song","sequence":"first","affiliation":[{"name":"Department of Neurology , The Third Affiliated Hospital of Sun Yat-sen University , Tianhe Road 600, 510000 Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Neuroscience Center, Department of Neurology , The First Hospital of Jilin University, Jilin University , Xinmin Street 1, 130021 Changchun , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fang","sequence":"additional","affiliation":[{"name":"Neuroscience Center, Department of Neurology , The First Hospital of Jilin University, Jilin University , Xinmin Street 1, 130021 Changchun , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[{"name":"The Second Hospital of Jilin University, Jilin University , Ziqiang Street 218, 130022 Changchun , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangding","family":"Liu","sequence":"additional","affiliation":[{"name":"Neuroscience Center, Department of Neurology , The First Hospital of Jilin University, Jilin University , Xinmin Street 1, 130021 Changchun , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Neuroscience Center, Department of Neurology , The First Hospital of Jilin University, Jilin University , Xinmin Street 1, 130021 Changchun , China"},{"name":"Department of Neurobiology, Care Sciences and Society , Karolinska Institute, Karolinska University Hospital , 17177 Solna , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-1130","authenticated-orcid":false,"given":"Xiujuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Neuroscience Center, Department of Neurology , The First Hospital of Jilin University, Jilin University , Xinmin Street 1, 130021 Changchun , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"2023112412354037661_j_revneuro-2023-0024_ref_001","doi-asserted-by":"crossref","unstructured":"Al-Saffar, A. and Al-Fatly, B. (2018). Acute motor axonal neuropathy in association with hepatitis E. Front. Neurol. 9: 62, https:\/\/doi.org\/10.3389\/fneur.2018.00062.","DOI":"10.3389\/fneur.2018.00062"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_002","doi-asserted-by":"crossref","unstructured":"Albert\u00ed, M.A., Alentorn, A., Mart\u00ednez-Yelamos, S., Mart\u00ednez-Matos, J.A., Povedano, M., Montero, J., and Casasnovas, C. (2011). Very early electrodiagnostic findings in Guillain-Barr\u00e9 syndrome. J.\u00a0Peripher. Nerv. Syst. 16: 136\u2013142, https:\/\/doi.org\/10.1111\/j.1529-8027.2011.00338.x.","DOI":"10.1111\/j.1529-8027.2011.00338.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_003","doi-asserted-by":"crossref","unstructured":"Alboudi, A.M., Sarathchandran, P., Geblawi, S.S., Kayed, D.M., Inshasi, J., Purayil, S.P., Almadani, A.B., and Katirji, B. (2019). Rescue treatment in patients with poorly responsive Guillain-Barre syndrome. SAGE Open Med. 7: 2050312119840195, https:\/\/doi.org\/10.1177\/2050312119840195.","DOI":"10.1177\/2050312119840195"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_209","doi-asserted-by":"crossref","unstructured":"Al-Hakem, H., Sindrup, S. H., Andersen, H., de la Cour, C. D., Lassen, L. L., van den Berg, B., Jacobs, B. C., and Harbo, T. (2019). Guillain-Barre syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity. J. Neurol. 266: 440\u2013449, https:\/\/doi.org\/10.1007\/s00415-018-9151-x.","DOI":"10.1007\/s00415-018-9151-x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_004","doi-asserted-by":"crossref","unstructured":"Allen, C.M., Ramsamy, S., Tarr, A.W., Tighe, P.J., Irving, W.L., Tanasescu, R., and Evans, J.R. (2021). Guillain-Barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination. Ann. Neurol. 90: 315\u2013318, https:\/\/doi.org\/10.1002\/ana.26144.","DOI":"10.1002\/ana.26144"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_005","doi-asserted-by":"crossref","unstructured":"Alshekhlee, A., Hussain, Z., Sultan, B., and Katirji, B. (2008). Guillain-Barr\u00e9 syndrome: incidence and mortality rates in US hospitals. Neurology 70: 1608\u20131613, https:\/\/doi.org\/10.1212\/01.wnl.0000310983.38724.d4.","DOI":"10.1212\/01.wnl.0000310983.38724.d4"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_225","doi-asserted-by":"crossref","unstructured":"Arami, M. A., Yazdchi, M., and Khandaghi, R. (2006). Epidemiology and characteristics of Guillain-Barre syndrome in the northwest of Iran. Ann. Saudi Med. 26: 22\u201327, https:\/\/doi.org\/10.5144\/0256-4947.2006.22.","DOI":"10.5144\/0256-4947.2006.22"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_006","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo, N.M., Ferreira, L.C., Dantas, D.P., Silva, D.S., Dos Santos, C.A., Cipolotti, R., and Martins-Filho, P.R. (2021). First report of SARS-CoV-2 detection in cerebrospinal fluid in a child with Guillain-Barr\u00e9 syndrome. Pediatr. Infect. Dis. J. 40: e274\u2013e276, https:\/\/doi.org\/10.1097\/inf.0000000000003146.","DOI":"10.1097\/INF.0000000000003146"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_007","doi-asserted-by":"crossref","unstructured":"Asthana, P., Vong, J.S., Kumar, G., Chang, R.C., Zhang, G., Sheikh, K.A., and Ma, C.H. (2016). Dissecting the role of anti-ganglioside antibodies in Guillain-Barr\u00e9 syndrome: an animal model approach. Mol. Neurobiol. 53: 4981\u20134991, https:\/\/doi.org\/10.1007\/s12035-015-9430-9.","DOI":"10.1007\/s12035-015-9430-9"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_008","doi-asserted-by":"crossref","unstructured":"Bae, J.S., Yuki, N., Kuwabara, S., Kim, J.K., Vucic, S., Lin, C.S., and Kiernan, M.C. (2014). Guillain-Barr\u00e9 syndrome in Asia. J.\u00a0Neurol. Neurosurg. Psychiatry 85: 907\u2013913, https:\/\/doi.org\/10.1136\/jnnp-2013-306212.","DOI":"10.1136\/jnnp-2013-306212"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_009","doi-asserted-by":"crossref","unstructured":"Baker, M.G., Kvalsvig, A., Zhang, J., Lake, R., Sears, A., and Wilson, N. (2012). Declining Guillain-Barre syndrome after campylobacteriosis control, New Zealand, 1988\u20132010. Emerg. Infect. Dis. 18: 226\u2013233, https:\/\/doi.org\/10.3201\/eid1802.111126.","DOI":"10.3201\/eid1802.111126"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_010","doi-asserted-by":"crossref","unstructured":"Bamberger, P.D. and Thys, D.M. (2005). Guillain-Barr\u00e9 syndrome in a patient with pancreatic cancer after an epidural-general anesthetic. Anesth. Analg. 100: 1197\u20131199, https:\/\/doi.org\/10.1213\/01.ane.0000144826.77316.ed.","DOI":"10.1213\/01.ANE.0000144826.77316.ED"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_011","doi-asserted-by":"crossref","unstructured":"Bao, L., Chen, X., Li, Q., Zhang, R., Shi, H., and Cui, G. (2020). Surgery and Guillain-Barr\u00e9 syndrome: a single-center retrospective study focused on clinical and electrophysiological subtypes. Neuropsychiatr. Dis. Treat. 16: 969\u2013974, https:\/\/doi.org\/10.2147\/ndt.s241128.","DOI":"10.2147\/NDT.S241128"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_012","doi-asserted-by":"crossref","unstructured":"Benedetti, M.D., Pugliatti, M., D\u2019Alessandro, R., Beghi, E., Chi\u00f2, A., Logroscino, G., Filippini, G., Galeotti, F., Massari, M., Santuccio, C., et al.. (2015). A multicentric prospective incidence study of Guillain-Barr\u00e9 syndrome in Italy. The ITANG Study. Neuroepidemiology 45: 90\u201399, https:\/\/doi.org\/10.1159\/000438752.","DOI":"10.1159\/000438752"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_013","doi-asserted-by":"crossref","unstructured":"Black, S., Eskola, J., Siegrist, C.A., Halsey, N., MacDonald, N., Law, B., Miller, E., Andrews, N., Stowe, J., Salmon, D., et al.. (2009). Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 374: 2115\u20132122, https:\/\/doi.org\/10.1016\/s0140-6736(09)61877-8.","DOI":"10.1016\/S0140-6736(09)61877-8"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_014","doi-asserted-by":"crossref","unstructured":"Burwen, D.R., Sandhu, S.K., MaCurdy, T.E., Kelman, J.A., Gibbs, J.M., Garcia, B., Markatou, M., Forshee, R.A., Izurieta, H.S., and Ball, R. (2012). Surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among the Medicare population, 2009\u20132010. Am. J.\u00a0Publ. Health 102: 1921\u20131927, https:\/\/doi.org\/10.2105\/ajph.2011.300510.","DOI":"10.2105\/AJPH.2011.300510"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_015","doi-asserted-by":"crossref","unstructured":"Cao-Lormeau, V.M., Blake, A., Mons, S., Last\u00e8re, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., et al.. (2016). Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387: 1531\u20131539, https:\/\/doi.org\/10.1016\/s0140-6736(16)00562-6.","DOI":"10.1016\/S0140-6736(16)00562-6"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_219","doi-asserted-by":"crossref","unstructured":"Capasso, A., Ompad, D. C., Vieira, D. L., Wilder-Smith, A., and Tozan, Y. (2019). Incidence of Guillain-Barre Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 zika virus epidemic: a systematic review and meta-analysis. PLoS Negl. Trop. Dis. 13: e0007622.","DOI":"10.1371\/journal.pntd.0007622"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_016","doi-asserted-by":"crossref","unstructured":"Capodivento, G., De Michelis, C., Carpo, M., Fancellu, R., Schirinzi, E., Severi, D., Visigalli, D., Franciotta, D., Manganelli, F., Siciliano, G., et al.. (2021). CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS. J.\u00a0Neurol. Neurosurg. Psychiatry 92: 303\u2013310, https:\/\/doi.org\/10.1136\/jnnp-2020-324445.","DOI":"10.1136\/jnnp-2020-324445"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_017","doi-asserted-by":"crossref","unstructured":"Caress, J.B., Castoro, R.J., Simmons, Z., Scelsa, S.N., Lewis, R.A., Ahlawat, A., and Narayanaswami, P. (2020). COVID-19-associated Guillain-Barre syndrome: the early pandemic experience. Muscle Nerve 62: 485\u2013491, https:\/\/doi.org\/10.1002\/mus.27024.","DOI":"10.1002\/mus.27024"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_018","doi-asserted-by":"crossref","unstructured":"Chen, Y., Ma, F., Zhang, J., Chu, X., and Xu, Y. (2014). Population incidence of Guillain-Barr\u00e9 syndrome in parts of China: three large populations in Jiangsu province, 2008\u20132010. Eur. J.\u00a0Neurol. 21: 124\u2013129.","DOI":"10.1111\/ene.12265"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_019","doi-asserted-by":"crossref","unstructured":"Chen, E.Y., Stratton, C., Mercer, B., Hohler, A., Tannoury, T.Y., and Tannoury, C. (2017). Guillain-Barr\u00e9 syndrome after elective spinal surgery. J.\u00a0Am. Acad. Orthop. Surg. 25: 587\u2013593, https:\/\/doi.org\/10.5435\/jaaos-d-16-00572.","DOI":"10.5435\/JAAOS-D-16-00572"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_020","doi-asserted-by":"crossref","unstructured":"Chen, Y., Zhang, J., Chu, X., Xu, Y., and Ma, F. (2020). Vaccines and the risk of Guillain-Barr\u00e9 syndrome. Eur. J.\u00a0Epidemiol. 35: 363\u2013370, https:\/\/doi.org\/10.1007\/s10654-019-00596-1.","DOI":"10.1007\/s10654-019-00596-1"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_215","doi-asserted-by":"crossref","unstructured":"Cheng, Q., Jiang, G. X., Fredrikson, S., Link, H., and De Pedro-Cuesta, J. (2000). Incidence of Guillain-Barre syndrome in Sweden 1996. Eur. J. Neurol. 7: 11\u201316.","DOI":"10.1046\/j.1468-1331.2000.00006.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_021","doi-asserted-by":"crossref","unstructured":"Cheng, Q., Wang, D.S., Jiang, G.X., Han, H., Zhang, Y., Wang, W.Z., and Fredrikson, S. (2002). Distinct pattern of age-specific incidence of Guillain-Barr\u00e9 syndrome in Harbin, China. J.\u00a0Am. Acad. Orthop. Surg. 249: 25\u201332, https:\/\/doi.org\/10.1046\/j.1529-8027.2002.02026_13.x.","DOI":"10.1007\/PL00007844"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_022","doi-asserted-by":"crossref","unstructured":"Chevret, S., Hughes, R.A., and Annane, D. (2017). Plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst. Rev. 2: Cd001798, https:\/\/doi.org\/10.1002\/14651858.cd001798.pub3.","DOI":"10.1002\/14651858.CD001798.pub3"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_023","doi-asserted-by":"crossref","unstructured":"Chiba, A., Kusunoki, S., Obata, H., Machinami, R., and Kanazawa, I. (1993). Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies. Neurology 43: 1911\u20131917, https:\/\/doi.org\/10.1212\/wnl.43.10.1911.","DOI":"10.1212\/WNL.43.10.1911"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_223","doi-asserted-by":"crossref","unstructured":"Chiesa, M., Decima, R., Bertinat, A., Poggi, L., Hackembruch, H., Montenegro, C., Chiparelli, H., and Vazquez, C. (2021). Incidence of Guillain-Barre syndrome in an Uruguayan population. A prospective cohort study. J. Peripher. Nerv. Syst. 26: 209\u2013215, https:\/\/doi.org\/10.1111\/jns.12450.","DOI":"10.1111\/jns.12450"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_024","doi-asserted-by":"crossref","unstructured":"Chmiela, T., Rzepka, M., Krzystanek, E., and Gorzkowska, A. (2021). A 50-year-old patient with Guillain-Barre syndrome after COVID-19: a case report. Medicina 57: 775, https:\/\/doi.org\/10.3390\/medicina57080775.","DOI":"10.3390\/medicina57080775"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_025","doi-asserted-by":"crossref","unstructured":"Chouillard, E. and Fingerhut, A. (2004). Guillain-Barr\u00e9 syndrome following oesophagectomy. ANZ J.\u00a0Surg. 74: 915\u2013916, https:\/\/doi.org\/10.1111\/j.1445-1433.2004.03198.x.","DOI":"10.1111\/j.1445-1433.2004.03198.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_212","doi-asserted-by":"crossref","unstructured":"Chroni, E., Papapetropoulos, S., Gioldasis, G., Ellul, J., Diamadopoulos, N., and Papapetropoulos, T. (2004). Guillain-Barre syndrome in Greece: seasonality and other clinico-epidemiological features. Eur. J. Neurol. 11: 383\u2013388, https:\/\/doi.org\/10.1111\/j.1468-1331.2004.00799.x.","DOI":"10.1111\/j.1468-1331.2004.00799.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_026","doi-asserted-by":"crossref","unstructured":"Civardi, C., Collini, A., Geda, D.J., and Geda, C. (2020). Antiganglioside antibodies in Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection. J.\u00a0Neurol. Neurosurg. Psychiatry 91: 1361\u20131362, https:\/\/doi.org\/10.1136\/jnnp-2020-324279.","DOI":"10.1136\/jnnp-2020-324279"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_027","doi-asserted-by":"crossref","unstructured":"Cr\u00e9ange, A., Shahrizaila, N., Salhi, H., Lefaucheur, J.P., and Yuki, N. (2014). Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barr\u00e9 syndrome presenting as acute motor conduction block neuropathy. J.\u00a0Peripher. Nerv. Syst. 19: 115\u2013120, https:\/\/doi.org\/10.1111\/jns5.12060.","DOI":"10.1111\/jns5.12060"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_214","doi-asserted-by":"crossref","unstructured":"Cuadrado, J. I., de Pedro-Cuesta, J., Ara, J. R., Cemillan, C. A., Diaz, M., Duarte, J., Fernandez, M. D., Fernandez, O., Garcia-Lopez, F., Garcia-Merino, A., et al.. (2004). Public health surveillance and incidence of adulthood Guillain-Barre syndrome in Spain, 1998\u20131999: the view from a sentinel network of neurologists. Neurol. Sci. 25: 57\u201365, https:\/\/doi.org\/10.1007\/s10072-004-0231-6.","DOI":"10.1007\/s10072-004-0231-6"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_028","doi-asserted-by":"crossref","unstructured":"Dalton, H.R., Kamar, N., van Eijk, J.J., McLean, B.N., Cintas, P., Bendall, R.P., and Jacobs, B.C. (2016). Hepatitis E virus and neurological injury. Nat. Rev. Neurol. 12: 77\u201385, https:\/\/doi.org\/10.1038\/nrneurol.2015.234.","DOI":"10.1038\/nrneurol.2015.234"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_029","unstructured":"De la, O. Pe\u00f1a D., Robles-Figueroa, M., Ch\u00e1vez-Pe\u00f1a, Q., and Bedolla-Barajas, M. (2015). Features of Guillain-Barre syndrome in adults: results of a university hospital. Rev. Med. Inst. Mex. Seguro Soc. 53: 678\u2013685."},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_030","doi-asserted-by":"crossref","unstructured":"Delannoy, A., Rudant, J., Chaignot, C., Bolgert, F., Mikaeloff, Y., and Weill, A. (2017). Guillain-Barr\u00e9 syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008\u20132013). J.\u00a0Peripher. Nerv. Syst. 22: 51\u201358, https:\/\/doi.org\/10.1111\/jns.12202.","DOI":"10.1111\/jns.12202"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_031","doi-asserted-by":"crossref","unstructured":"Diez-Porras, L., Verg\u00e9s, E., Gil, F., Vidal, M.J., Massons, J., and Arboix, A. (2020). Guillain-Barr\u00e9-Strohl syndrome and COVID-19: case report and literature review. Neuromuscul. Disord. 30: 859\u2013861, https:\/\/doi.org\/10.1016\/j.nmd.2020.08.354.","DOI":"10.1016\/j.nmd.2020.08.354"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_032","doi-asserted-by":"crossref","unstructured":"Dimachkie, M.M. and Barohn, R.J. (2013). Guillain-Barr\u00e9 syndrome and variants. Neurol. Clin. 31: 491\u2013510, https:\/\/doi.org\/10.1016\/j.ncl.2013.01.005.","DOI":"10.1016\/j.ncl.2013.01.005"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_033","doi-asserted-by":"crossref","unstructured":"Dirlikov, E., Kniss, K., Major, C., Thomas, D., Virgen, C.A., Mayshack, M., Asher, J., Mier, Y., Teran-Romero, L., Salinas, J.L., et al.. (2017). Guillain-Barr\u00e9 syndrome and healthcare needs during Zika virus transmission, Puerto Rico, 2016. Emerg. Infect. Dis. 23: 134\u2013136, https:\/\/doi.org\/10.3201\/eid2301.161290.","DOI":"10.3201\/eid2301.161290"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_221","doi-asserted-by":"crossref","unstructured":"Dirlikov, E., Major, C. G., Medina, N. A., Lugo-Robles, R., Matos, D., Munoz-Jordan, J. L., Colon-Sanchez, C., Garcia, M., Olivero-Segarra, M., Malave, G., et al.. (2018). Clinical features of Guillain-Barre syndrome with vs without Zika virus infection, Puerto Rico, 2016. JAMA Neurol. 75: 1089\u20131097, https:\/\/doi.org\/10.1001\/jamaneurol.2018.1058.","DOI":"10.1001\/jamaneurol.2018.1058"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_034","doi-asserted-by":"crossref","unstructured":"Doets, A.Y., Jacobs, B.C., and van Doorn, P.A. (2018a). Advances in management of Guillain-Barr\u00e9 syndrome. Curr. Opin. Neurol. 31: 541\u2013550, https:\/\/doi.org\/10.1097\/wco.0000000000000602.","DOI":"10.1097\/WCO.0000000000000602"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_035","doi-asserted-by":"crossref","unstructured":"Doets, A.Y., Verboon, C., van den Berg, B., Harbo, T., Cornblath, D.R., Willison, H.J., Islam, Z., Attarian, S., Barroso, F.A., Bateman, K., et al.. (2018b). Regional variation of Guillain-Barr\u00e9 syndrome. Brain 141: 2866\u20132877, https:\/\/doi.org\/10.1093\/brain\/awy232.","DOI":"10.1093\/brain\/awy232"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_036","doi-asserted-by":"crossref","unstructured":"Dourado, M.E., Felix, R.H., da Silva, W.K., Queiroz, J.W., and Jeronimo, S.M. (2012). Clinical characteristics of Guillain-Barre syndrome in a tropical country: a Brazilian experience. Acta Neurol. Scand. 125: 47\u201353, https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01503.x.","DOI":"10.1111\/j.1600-0404.2011.01503.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_037","doi-asserted-by":"crossref","unstructured":"Dourado J\u00fanior, M.E.T., Fernandes, U.T., Ramos, E.S., Vital, A.L.F., Urbano, J.C.C., Queiroz, J.W., and Jeronimo, S.M.B. (2018). Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil. Acta Neurol. Scand. 138: 459\u2013462, https:\/\/doi.org\/10.1111\/ane.12995.","DOI":"10.1111\/ane.12995"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_038","doi-asserted-by":"crossref","unstructured":"Durand, M.C., Porcher, R., Orlikowski, D., Aboab, J., Devaux, C., Clair, B., Annane, D., Gaillard, J.L., Lofaso, F., Raphael, J.C., et al.. (2006). Clinical and electrophysiological predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a prospective study. Lancet Neurol. 5: 1021\u20131028, https:\/\/doi.org\/10.1016\/s1474-4422(06)70603-2.","DOI":"10.1016\/S1474-4422(06)70603-2"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_039","doi-asserted-by":"crossref","unstructured":"Esposito, S. and Longo, M.R. (2017). Guillain-Barr\u00e9 syndrome. Autoimmun. Rev. 16: 96\u2013101, https:\/\/doi.org\/10.1016\/j.autrev.2016.09.022.","DOI":"10.1016\/j.autrev.2016.09.022"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_040","doi-asserted-by":"crossref","unstructured":"Fan, Q., Hu, Y., Wang, X., and Zhao, B. (2021). Guillain-Barr\u00e9 syndrome in patients treated with immune checkpoint inhibitors. J.\u00a0Am. Acad. Orthop. Surg. 268: 2169\u20132174, https:\/\/doi.org\/10.1007\/s00415-021-10404-0.","DOI":"10.1007\/s00415-021-10404-0"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_041","doi-asserted-by":"crossref","unstructured":"Fantini, J., Di Scala, C., Chahinian, H., and Yahi, N. (2020). Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int. J.\u00a0Antimicrob. Agents 55: 105960, https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105960.","DOI":"10.1016\/j.ijantimicag.2020.105960"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_042","doi-asserted-by":"crossref","unstructured":"Farbu, E., Rudolph, T., and Stefansdottir, S. (2016). Guillain Barr\u00e9 syndrome--incidence and clinical course in southern Rogaland, Norway. Clin. Neurol. Neurosurg. 141: 33\u201337, https:\/\/doi.org\/10.1016\/j.clineuro.2015.12.008.","DOI":"10.1016\/j.clineuro.2015.12.008"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_043","doi-asserted-by":"crossref","unstructured":"Figueras, A., Morales-Olivas, F.J., Capell\u00e0, D., Palop, V., and Laporte, J.R. (1992). Bovine gangliosides and acute motor polyneuropathy. BMJ 305: 1330\u20131331, https:\/\/doi.org\/10.1136\/bmj.305.6865.1330.","DOI":"10.1136\/bmj.305.6865.1330"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_044","doi-asserted-by":"crossref","unstructured":"Fokke, C., van den Berg, B., Drenthen, J., Walgaard, C., van Doorn, P.A., and Jacobs, B.C. (2014). Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain 137: 33\u201343, https:\/\/doi.org\/10.1093\/brain\/awt285.","DOI":"10.1093\/brain\/awt285"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_045","doi-asserted-by":"crossref","unstructured":"Fokkink, W.R., Walgaard, C., Kuitwaard, K., Tio-Gillen, A.P., van Doorn, P.A., and Jacobs, B.C. (2017). Association of albumin levels with outcome in intravenous immunoglobulin-treated guillain-barr\u00e9 syndrome. JAMA Neurol. 74: 189\u2013196, https:\/\/doi.org\/10.1001\/jamaneurol.2016.4480.","DOI":"10.1001\/jamaneurol.2016.4480"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_046","doi-asserted-by":"crossref","unstructured":"Forsberg, A., Press, R., and Holmqvist, L.W. (2012). Residual disability 10 years after falling ill in Guillain-Barr\u00e9 syndrome: a prospective follow-up study. J.\u00a0Neurol. Sci. 317: 74\u201379, https:\/\/doi.org\/10.1016\/j.jns.2012.02.026.","DOI":"10.1016\/j.jns.2012.02.026"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_047","doi-asserted-by":"crossref","unstructured":"Foubert-Samier, A., Penchet, G., Yekhlef, F., Lemasson, G., and Sibon, I. (2005). Guillain-Barr\u00e9 syndrome secondary to cranial surgery: direct or fortuitous relationship? Neurochirurgie 51: 604\u2013606, https:\/\/doi.org\/10.1016\/s0028-3770(05)83637-9.","DOI":"10.1016\/S0028-3770(05)83637-9"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_048","doi-asserted-by":"crossref","unstructured":"Funes, S.C., Chiari, M.E., Com\u00edn, R., Irazoqui, F.J., and Nores, G.A. (2017). Experimental Guillain-Barre syndrome induced by immunization with gangliosides: keyhole limpet hemocyanin is required for disease triggering. Biochim. Biophys. Acta Mol. Basis Dis. 1863: 1473\u20131478, https:\/\/doi.org\/10.1016\/j.bbadis.2017.02.007.","DOI":"10.1016\/j.bbadis.2017.02.007"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_049","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Grimshaw, M., Michel-Ch\u00e1vez, A., Vera-Zertuche, J.M., Galnares-Olalde, J.A., Hern\u00e1ndez-Vanegas, L.E., Figueroa-Cucurachi, M., Paredes-Ceballos, O., Reyes-Ter\u00e1n, G., Carbajal-Sandoval, G., Ceballos-Liceaga, S.E., et al.. (2021). Guillain-Barr\u00e9 syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clin. Immunol. 230: 108818, https:\/\/doi.org\/10.1016\/j.clim.2021.108818.","DOI":"10.1016\/j.clim.2021.108818"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_050","doi-asserted-by":"crossref","unstructured":"Gensicke, H., Datta, A.N., Dill, P., Schindler, C., and Fischer, D. (2012). Increased incidence of Guillain-Barr\u00e9 syndrome after surgery. Eur. J.\u00a0Neurol. 19: 1239\u20131244, https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03730.x.","DOI":"10.1111\/j.1468-1331.2012.03730.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_051","doi-asserted-by":"crossref","unstructured":"Godschalk, P.C., Heikema, A.P., Gilbert, M., Komagamine, T., Ang, C.W., Glerum, J., Brochu, D., Li, J., Yuki, N., Jacobs, B.C., et al.. (2004). The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J.\u00a0Clin. Invest. 114: 1659\u20131665, https:\/\/doi.org\/10.1172\/jci200415707.","DOI":"10.1172\/JCI200415707"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_052","doi-asserted-by":"crossref","unstructured":"Gong, Q., Liu, S., Liu, Y., Yao, J., Fu, X., Xiao, Z., and Lu, Z. (2021). Guillain-Barr\u00e9 syndrome triggered by surgery in a Chinese population: a multicenter retrospective study. BMC Neurol. 21: 40, https:\/\/doi.org\/10.1186\/s12883-021-02067-1.","DOI":"10.1186\/s12883-021-02067-1"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_053","doi-asserted-by":"crossref","unstructured":"Goodfellow, J.A. and Willison, H.J. (2016). Guillain-Barr\u00e9 syndrome: a century of progress. Nat. Rev. Neurol. 12: 723\u2013731, https:\/\/doi.org\/10.1038\/nrneurol.2016.172.","DOI":"10.1038\/nrneurol.2016.172"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_054","doi-asserted-by":"crossref","unstructured":"Govoni, V., Granieri, E., Manconi, M., Capone, J., and Casetta, I. (2003). Is there a decrease in Guillain-Barr\u00e9 syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. J.\u00a0Neurol. Sci. 216: 99\u2013103, https:\/\/doi.org\/10.1016\/s0022-510x(03)00215-6.","DOI":"10.1016\/S0022-510X(03)00215-6"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_055","doi-asserted-by":"crossref","unstructured":"Green, C., Baker, T., and Subramaniam, A. (2018). Predictors of respiratory failure in patients with Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis. Med. J.\u00a0Aust. 208: 181\u2013188, https:\/\/doi.org\/10.5694\/mja17.00552.","DOI":"10.5694\/mja17.00552"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_056","doi-asserted-by":"crossref","unstructured":"Greene, S.K., Rett, M.D., Vellozzi, C., Li, L., Kulldorff, M., Marcy, S.M., Daley, M.F., Belongia, E.A., Baxter, R., Fireman, B.H., et al.. (2013). Guillain-Barr\u00e9 syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the vaccine safety datalink, 2009\u20132011. PLoS One 8: e67185, https:\/\/doi.org\/10.1371\/journal.pone.0067185.","DOI":"10.1371\/journal.pone.0067185"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_057","doi-asserted-by":"crossref","unstructured":"Gu, B.M., Ko, H.H., Lee, H.K., Ra, Y.J., Lee, H.S., and Kim, H.S. (2021). Guillain-Barr\u00e9 syndrome after lung transplantation in the immediate postoperative period. J.\u00a0Chest Surg. 54: 396\u2013399, https:\/\/doi.org\/10.5090\/kjtcs.20.074.","DOI":"10.5090\/jcs.20.074"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_058","doi-asserted-by":"crossref","unstructured":"Haber, P., Sejvar, J., Mikaeloff, Y., and DeStefano, F. (2009). Vaccines and Guillain-Barr\u00e9 syndrome. Drug Saf. 32: 309\u2013323, https:\/\/doi.org\/10.2165\/00002018-200932040-00005.","DOI":"10.2165\/00002018-200932040-00005"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_059","doi-asserted-by":"crossref","unstructured":"Hadden, R.D., Cornblath, D.R., Hughes, R.A., Zielasek, J., Hartung, H.P., Toyka, K.V., and Swan, A.V. (1998). Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Ann. Neurol. 44: 780\u2013788, https:\/\/doi.org\/10.1002\/ana.410440512.","DOI":"10.1002\/ana.410440512"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_060","doi-asserted-by":"crossref","unstructured":"Hafer-Macko, C., Hsieh, S.T., Li, C.Y., Ho, T.W., Sheikh, K., Cornblath, D.R., McKhann, G.M., Asbury, A.K., and Griffin, J.W. (1996). Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40: 635\u2013644, https:\/\/doi.org\/10.1002\/ana.410400414.","DOI":"10.1002\/ana.410400414"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_217","doi-asserted-by":"crossref","unstructured":"Hafsteinsdottir, B., Olafsson, E., and Jakobsson, F. (2018). Incidence and outcome of Guillain-Barre syndrome in Iceland: a population-based study. Acta Neurol. Scand. 138: 454\u2013458, https:\/\/doi.org\/10.1111\/ane.13000.","DOI":"10.1111\/ane.13000"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_061","doi-asserted-by":"crossref","unstructured":"Halstead, S.K., Zitman, F.M., Humphreys, P.D., Greenshields, K., Verschuuren, J.J., Jacobs, B.C., Rother, R.P., Plomp, J.J., and Willison, H.J. (2008). Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131: 1197\u20131208, https:\/\/doi.org\/10.1093\/brain\/awm316.","DOI":"10.1093\/brain\/awm316"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_062","doi-asserted-by":"crossref","unstructured":"Hao, Y., Wang, W., Jacobs, B.C., Qiao, B., Chen, M., Liu, D., Feng, X., and Wang, Y. (2019). Antecedent infections in Guillain-Barr\u00e9 syndrome: a single-center, prospective study. Ann. Clin. Transl. Neurol. 6: 2510\u20132517, https:\/\/doi.org\/10.1002\/acn3.50946.","DOI":"10.1002\/acn3.50946"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_218","doi-asserted-by":"crossref","unstructured":"Hauck, L. J., White, C., Feasby, T. E., Zochodne, D. W., Svenson, L. W., and Hill, M. D. (2008). Incidence of Guillain-Barre syndrome in Alberta, Canada: an administrative data study. J. Neurol. Neurosurg. Psychiatry. 79: 318\u2013320, https:\/\/doi.org\/10.1136\/jnnp.2007.118810.","DOI":"10.1136\/jnnp.2007.118810"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_063","unstructured":"Hekmat, M., Ghaderi, H., Foroughi, M., and Mirjafari, S.A. (2016). Guillain-Barr\u00e9 syndrome after coronary artery bypass graft surgery: a case report. Acta Med. Iran. 54: 76\u201378."},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_211","doi-asserted-by":"crossref","unstructured":"Hense, S., Schink, T., Kreisel, S. H., Marcelon, L., Simondon, F., Tahden, M., and Garbe, E. (2014). Estimation of background incidence rates of Guillain-Barre syndrome in Germany - a retrospective cohort study with electronic healthcare data. Neuroepidemiology 43: 244\u2013252, https:\/\/doi.org\/10.1159\/000369344.","DOI":"10.1159\/000369344"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_064","doi-asserted-by":"crossref","unstructured":"Ho, T.W., Mishu, B., Li, C.Y., Gao, C.Y., Cornblath, D.R., Griffin, J.W., Asbury, A.K., Blaser, M.J., and McKhann, G.M. (1995). Guillain-Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni\u00a0infection and anti-glycolipid antibodies. Brain 118(Pt 3): 597\u2013605, https:\/\/doi.org\/10.1093\/brain\/118.3.597.","DOI":"10.1093\/brain\/118.3.597"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_065","doi-asserted-by":"crossref","unstructured":"Hocker, S., Nagarajan, E., Rubin, M., and Wijdicks, E.F.M. (2018). Clinical factors associated with Guillain-Barr\u00e9 syndrome following surgery. Neurol. Clin. Pract. 8: 201\u2013206, https:\/\/doi.org\/10.1212\/cpj.0000000000000451.","DOI":"10.1212\/CPJ.0000000000000451"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_066","doi-asserted-by":"crossref","unstructured":"Houliston, R.S., Koga, M., Li, J., Jarrell, H.C., Richards, J.C., Vitiazeva, V., Schweda, E.K., Yuki, N., and Gilbert, M. (2007). A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry 46: 8164\u20138171, https:\/\/doi.org\/10.1021\/bi700685s.","DOI":"10.1021\/bi700685s"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_227","doi-asserted-by":"crossref","unstructured":"Howlett, W. P., Vedeler, C. A., Nyland, H., and Aarli, J. A. (1996). Guillain-Barre syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway. Acta Neurol. Scand. 93: 44\u201349, https:\/\/doi.org\/10.1111\/j.1600-0404.1996.tb00169.x.","DOI":"10.1111\/j.1600-0404.1996.tb00169.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_067","doi-asserted-by":"crossref","unstructured":"Huang, S.L., Qi, H.G., Liu, J.J., Huang, Y.J., and Xiang, L. (2015). A rare complication of spine surgery: Guillain-Barr\u00e9 syndrome. World Neurosurg. 84: 697\u2013701, https:\/\/doi.org\/10.1016\/j.wneu.2015.04.045.","DOI":"10.1016\/j.wneu.2015.04.045"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_068","doi-asserted-by":"crossref","unstructured":"Hughes, R.A. and Cornblath, D.R. (2005). Guillain-Barr\u00e9 syndrome. Lancet 366: 1653\u20131666, https:\/\/doi.org\/10.1016\/s0140-6736(05)67665-9.","DOI":"10.1016\/S0140-6736(05)67665-9"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_070","doi-asserted-by":"crossref","unstructured":"Hughes, R.A., Swan, A.V., Rapha\u00ebl, J.C., Annane, D., van Koningsveld, R., and van Doorn, P.A. (2007). Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review. Brain 130: 2245\u20132257.","DOI":"10.1093\/brain\/awm004"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_072","doi-asserted-by":"crossref","unstructured":"Hughes, R.A., Brassington, R., Gunn, A.A., and van Doorn, P.A. (2016). Corticosteroids for guillain-barr\u00e9 syndrome. Cochrane Database Syst. Rev. 10: Cd001446, https:\/\/doi.org\/10.1002\/14651858.cd001446.pub5.","DOI":"10.1002\/14651858.CD001446.pub5"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_073","doi-asserted-by":"crossref","unstructured":"Hui, A.C., Chow, K.M., Tang, A.S., Fu, M., Kay, R., and Wong, K.S. (2005). Electrophysiological, clinical and epidemiological study of Guillain-Barre Syndrome in Hong Kong Chinese. J.\u00a0Clin. Neurosci. 12: 134\u2013136.","DOI":"10.1016\/j.jocn.2003.10.018"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_074","doi-asserted-by":"crossref","unstructured":"Illa, I., Ortiz, N., Gallard, E., Juarez, C., Grau, J.M., and Dalakas, M.C. (1995). Acute axonal Guillain-Barr\u00e9 syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol. 38: 218\u2013224, https:\/\/doi.org\/10.1002\/ana.410380214.","DOI":"10.1002\/ana.410380214"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_075","doi-asserted-by":"crossref","unstructured":"Ishaque, T., Islam, M.B., Ara, G., Endtz, H.P., Mohammad, Q.D., Jacobs, B.C., and Islam, Z. (2017). High mortality from Guillain-Barr\u00e9 syndrome in Bangladesh. J.\u00a0Peripher. Nerv. Syst. 22: 121\u2013126, https:\/\/doi.org\/10.1111\/jns.12215.","DOI":"10.1111\/jns.12215"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_076","doi-asserted-by":"crossref","unstructured":"Islam, Z., Jacobs, B.C., van Belkum, A., Mohammad, Q.D., Islam, M.B., Herbrink, P., Diorditsa, S., Luby, S.P., Talukder, K.A., and Endtz, H.P. (2010). Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Neurology 74: 581\u2013587, https:\/\/doi.org\/10.1212\/wnl.0b013e3181cff735.","DOI":"10.1212\/WNL.0b013e3181cff735"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_077","doi-asserted-by":"crossref","unstructured":"Islam, Z., Jacobs, B.C., Islam, M.B., Mohammad, Q.D., Diorditsa, S., and Endtz, H.P. (2011). High incidence of Guillain-Barre syndrome in children, Bangladesh. Emerg. Infect. Dis. 17: 1317\u20131318.","DOI":"10.3201\/eid1707.101999"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_078","doi-asserted-by":"crossref","unstructured":"Islam, M.B., Islam, Z., Rahman, S., Endtz, H.P., Vos, M.C., van der Jagt, M., van Doorn, P.A., Jacobs, B.C., and Mohammad, Q.D. (2017). Small volume plasma exchange for Guillain-Barr\u00e9 syndrome in resource poor settings: a safety and feasibility study. Pilot Feasibility Stud. 3: 40, https:\/\/doi.org\/10.1186\/s40814-017-0185-0.","DOI":"10.1186\/s40814-017-0185-0"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_079","doi-asserted-by":"crossref","unstructured":"Islam, B., Islam, Z., Rahman, S., Endtz, H.P., Vos, M.C., van der Jagt, M., van Doorn, P.A., Jacobs, B.C., and Mohammad, Q.D. (2018). Small volume plasma exchange for Guillain-Barr\u00e9 syndrome in resource-limited settings: a phase II safety and feasibility study. BMJ Open 8: e022862, https:\/\/doi.org\/10.1136\/bmjopen-2018-022862.","DOI":"10.1136\/bmjopen-2018-022862"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_080","doi-asserted-by":"crossref","unstructured":"Israeli, E., Agmon-Levin, N., Blank, M., Chapman, J., and Shoenfeld, Y. (2012). Guillain-Barr\u00e9 syndrome--a classical autoimmune disease triggered by infection or vaccination. Clin. Rev. Allergy Immunol. 42: 121\u2013130.","DOI":"10.1007\/s12016-010-8213-3"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_081","doi-asserted-by":"crossref","unstructured":"Jackson, B.R., Zegarra, J.A., L\u00f3pez-Gatell, H., Sejvar, J., Arzate, F., Waterman, S., N\u00fa\u00f1ez, A.S., L\u00f3pez, B., Weiss, J., Cruz, R.Q., et al.. (2014). Binational outbreak of Guillain-Barr\u00e9 syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011. Epidemiol. Infect. 142: 1089\u20131099, https:\/\/doi.org\/10.1017\/s0950268813001908.","DOI":"10.1017\/S0950268813001908"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_082","doi-asserted-by":"crossref","unstructured":"Jasti, A.K., Selmi, C., Sarmiento-Monroy, J.C., Vega, D.A., Anaya, J.M., and Gershwin, M.E. (2016). Guillain-Barr\u00e9 syndrome: causes, immunopathogenic mechanisms and treatment. Expet Rev. Clin. Immunol. 12: 1175\u20131189, https:\/\/doi.org\/10.1080\/1744666x.2016.1193006.","DOI":"10.1080\/1744666X.2016.1193006"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_083","doi-asserted-by":"crossref","unstructured":"Johnson, D.B., Manouchehri, A., Haugh, A.M., Quach, H.T., Balko, J.M., Lebrun-Vignes, B., Mammen, A., Moslehi, J.J., and Salem, J.E. (2019). Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study. J.\u00a0Immunother. Cancer 7: 134, https:\/\/doi.org\/10.1186\/s40425-019-0617-x.","DOI":"10.1186\/s40425-019-0617-x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_084","doi-asserted-by":"crossref","unstructured":"Kaida, K. (2019). Guillain-Barr\u00e9 syndrome. Adv. Exp. Med. Biol. 1190: 323\u2013331, https:\/\/doi.org\/10.1007\/978-981-32-9636-7_20.","DOI":"10.1007\/978-981-32-9636-7_20"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_085","doi-asserted-by":"crossref","unstructured":"Kannan Kanikannan, M.A., Durga, P., Venigalla, N.K., Kandadai, R.M., Jabeen, S.A., and Borgohain, R. (2014). Simple bedside predictors of mechanical ventilation in patients with Guillain-Barre syndrome. J.\u00a0Crit. Care 29: 219\u2013223, https:\/\/doi.org\/10.1016\/j.jcrc.2013.10.026.","DOI":"10.1016\/j.jcrc.2013.10.026"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_086","doi-asserted-by":"crossref","unstructured":"Kao, J.C., Brickshawana, A., and Liewluck, T. (2018). Neuromuscular complications of programmed cell death-1 (PD-1) inhibitors. Curr. Neurol. Neurosci. Rep. 18: 63, https:\/\/doi.org\/10.1007\/s11910-018-0878-7.","DOI":"10.1007\/s11910-018-0878-7"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_087","doi-asserted-by":"crossref","unstructured":"Kasemsap, N., Vorasoot, N., Kongbunkiat, K., Tiamkao, S., Chotmongkol, V., Sawanyawisuth, K., and Panitchote, A. (2021). The epidemiology of Guillain-Barr\u00e9 syndrome in Thailand over 13 years (2005\u20132017): a nationwide population-based retrospective cohort study. J.\u00a0Peripher. Nerv. Syst. 26: 202\u2013208, https:\/\/doi.org\/10.1111\/jns.12453.","DOI":"10.1111\/jns.12453"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_088","doi-asserted-by":"crossref","unstructured":"Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P.M., Foster, M., Record, C.J., Keh, R.Y.S., Fehmi, J., Paterson, R.W., et al.. (2021). Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome. Brain 144: 682\u2013693, https:\/\/doi.org\/10.1093\/brain\/awaa433.","DOI":"10.1093\/brain\/awaa433"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_089","doi-asserted-by":"crossref","unstructured":"Keh, R.Y.S., Scanlon, S., Datta-Nemdharry, P., Donegan, K., Cavanagh, S., Foster, M., Skelland, D., Palmer, J., Machado, P.M., Keddie, S., et al.. (2023). COVID-19 vaccination and Guillain-Barr\u00e9 syndrome: analyses using the National Immunoglobulin Database. Brain 146: 739\u2013748, https:\/\/doi.org\/10.1093\/brain\/awac067.","DOI":"10.1093\/brain\/awac067"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_090","doi-asserted-by":"crossref","unstructured":"Khan, F., Sharma, P., Pandey, S., Sharma, D., Vijayavarman, V., Kumar, N., Shukla, S., Dandu, H., Jain, A., Garg, R.K., et al.. (2021). COVID-19-associated Guillain-Barre syndrome: postinfectious alone or neuroinvasive too? J.\u00a0Med. Virol. 93: 6045\u20136049, https:\/\/doi.org\/10.1002\/jmv.27159.","DOI":"10.1002\/jmv.27159"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_091","doi-asserted-by":"crossref","unstructured":"Kieseier, B.C., Kiefer, R., Gold, R., Hemmer, B., Willison, H.J., and Hartung, H.P. (2004). Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30: 131\u2013156, https:\/\/doi.org\/10.1002\/mus.20076.","DOI":"10.1002\/mus.20076"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_092","doi-asserted-by":"crossref","unstructured":"Kim, J.K., Bae, J.S., Kim, D.S., Kusunoki, S., Kim, J.E., Kim, J.S., Park, Y.E., Park, K.J., Song, H.S., Kim, S.Y., et al.. (2014). Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain-Barr\u00e9 syndrome in Korea: a nationwide multicenter study. J.\u00a0Clin. Neurol. 10: 94\u2013100, https:\/\/doi.org\/10.3988\/jcn.2014.10.2.94.","DOI":"10.3988\/jcn.2014.10.2.94"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_093","doi-asserted-by":"crossref","unstructured":"Koike, H., Fukami, Y., Nishi, R., Kawagashira, Y., Iijima, M., Katsuno, M., and Sobue, G. (2020). Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome. J.\u00a0Neurol. Neurosurg. Psychiatry 91: 650\u2013659.","DOI":"10.1136\/jnnp-2019-322479"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_226","doi-asserted-by":"crossref","unstructured":"Kim, A. Y., Lee, H., and Kang, H. Y. (2021). Epidemiological features and economic burden of Guillain-Barre syndrome in South Korea: a nationwide population-based study. J. Clin. Neurol. 17: 257\u2013264, https:\/\/doi.org\/10.3988\/jcn.2021.17.2.257.","DOI":"10.3988\/jcn.2021.17.2.257"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_094","doi-asserted-by":"crossref","unstructured":"Koike, H., Chiba, A., and Katsuno, M. (2021). Emerging infection, vaccination, and Guillain-Barre syndrome: a review. Neurol. Ther. 10: 523\u2013537, https:\/\/doi.org\/10.1007\/s40120-021-00261-4.","DOI":"10.1007\/s40120-021-00261-4"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_095","doi-asserted-by":"crossref","unstructured":"Kopscik, M.R., Giourgas, B.K., and Presley, B.C. (2020). A case report of acute motor and sensory polyneuropathy as the presenting symptom of SARS-CoV-2. Clin. Pract. Cases Emerg. Med. 4: 352\u2013354, https:\/\/doi.org\/10.5811\/cpcem.2020.6.48683.","DOI":"10.5811\/cpcem.2020.6.48683"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_096","doi-asserted-by":"crossref","unstructured":"Kuitwaard, K., Bos-Eyssen, M.E., Blomkwist-Markens, P.H., and van Doorn, P.A. (2009). Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J.\u00a0Peripher. Nerv. Syst. 14: 310\u2013315, https:\/\/doi.org\/10.1111\/j.1529-8027.2009.00243.x.","DOI":"10.1111\/j.1529-8027.2009.00243.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_097","doi-asserted-by":"crossref","unstructured":"Kutlesa, M., Santini, M., Krajinovi\u0107, V., Raffanelli, D., and Barsi\u0107, B. (2010). Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocrit. Care 13: 98\u2013100, https:\/\/doi.org\/10.1007\/s12028-010-9365-y.","DOI":"10.1007\/s12028-010-9365-y"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_098","doi-asserted-by":"crossref","unstructured":"Kuwabara, S. and Yuki, N. (2013). Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies. Lancet Neurol. 12: 1180\u20131188, https:\/\/doi.org\/10.1016\/s1474-4422(13)70215-1.","DOI":"10.1016\/S1474-4422(13)70215-1"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_099","doi-asserted-by":"crossref","unstructured":"Landi, G., D\u2019Alessandro, R., Dossi, B.C., Ricci, S., Simone, I.L., and Ciccone, A. (1993). Guillain-Barr\u00e9 syndrome after exogenous gangliosides in Italy. BMJ 307: 1463\u20131464, https:\/\/doi.org\/10.1136\/bmj.307.6917.1463.","DOI":"10.1136\/bmj.307.6917.1463"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_100","doi-asserted-by":"crossref","unstructured":"Larrosa-Haro, A., Macias-Rosales, R., S\u00e1nchez-Ram\u00edrez, C.A., Cort\u00e9s-L\u00f3pez, M.C., and Aguilar-Benavides, S. (2010). Seasonal variation of enteropathogens in infants and preschoolers with acute diarrhea in western Mexico. J.\u00a0Pediatr. Gastroenterol. Nutr. 51: 534\u2013536, https:\/\/doi.org\/10.1097\/mpg.0b013e3181df5b66.","DOI":"10.1097\/MPG.0b013e3181df5b66"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_101","doi-asserted-by":"crossref","unstructured":"LatovKoski, N.C., Walicke, P., and Sch\u00f6nh\u00f6fer, P. (1991). Guillain-Barr\u00e9 syndrome and parenteral gangliosides. Lancet 338: 757, https:\/\/doi.org\/10.1016\/0140-6736(91)91475-a.","DOI":"10.1016\/0140-6736(91)91475-A"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_102","doi-asserted-by":"crossref","unstructured":"Lehmann, H.C., Hartung, H.P., Kieseier, B.C., and Hughes, R.A. (2010). Guillain-Barr\u00e9 syndrome after exposure to influenza virus. Lancet Infect. Dis. 10: 643\u2013651, https:\/\/doi.org\/10.1016\/s1473-3099(10)70140-7.","DOI":"10.1016\/S1473-3099(10)70140-7"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_103","doi-asserted-by":"crossref","unstructured":"Leonhard, S.E., Mandarakas, M.R., Gondim, F.A.A., Bateman, K., Ferreira, M.L.B., Cornblath, D.R., van Doorn, P.A., Dourado, M.E., Hughes, R.A.C., Islam, B., et al.. (2019). Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat. Rev. Neurol. 15: 671\u2013683, https:\/\/doi.org\/10.1038\/s41582-019-0250-9.","DOI":"10.1038\/s41582-019-0250-9"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_104","doi-asserted-by":"crossref","unstructured":"Liou, L.S., Chung, C.H., Wu, Y.T., Tsao, C.H., Wu, Y.F., Chien, W.C., and Chang, C.Y. (2016). Epidemiology and prognostic factors of inpatient mortality of Guillain-Barr\u00e9 syndrome: a nationwide population study over 14years in Asian country. J.\u00a0Neurol. Sci. 369: 159\u2013164, https:\/\/doi.org\/10.1016\/j.jns.2016.08.014.","DOI":"10.1016\/j.jns.2016.08.014"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_105","doi-asserted-by":"crossref","unstructured":"Liu, S., Xiao, Z., Lou, M., Ji, F., Shao, B., Dai, H., Luo, C., Hu, B., Zhou, R., Zou, Z., et al.. (2018). Guillain-Barr\u00e9 syndrome in southern China: retrospective analysis of hospitalised patients from 14 provinces in the area south of the Huaihe River. J.\u00a0Neurol. Neurosurg. Psychiatry 89: 618\u2013626, https:\/\/doi.org\/10.1136\/jnnp-2017-316930.","DOI":"10.1136\/jnnp-2017-316930"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_106","doi-asserted-by":"crossref","unstructured":"Lucchese, G. and Fl\u00f6el, A. (2020). SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones 25: 731\u2013735, https:\/\/doi.org\/10.1007\/s12192-020-01145-6.","DOI":"10.1007\/s12192-020-01145-6"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_107","doi-asserted-by":"crossref","unstructured":"Lucchese, G. and Kanduc, D. (2016). Zika virus and autoimmunity: from microcephaly to Guillain-Barr\u00e9 syndrome, and beyond. Autoimmun. Rev. 15: 801\u2013808, https:\/\/doi.org\/10.1016\/j.autrev.2016.03.020.","DOI":"10.1016\/j.autrev.2016.03.020"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_222","doi-asserted-by":"crossref","unstructured":"Machado-Alba, J. E., Machado-Duque, M. E., Gaviria-Mendoza, A., and Orozco-Giraldo, V. (2016). Diagnosis of neurological disorders and the Zika virus epidemic in Colombia 2014 -2016. Int. J. Infect. Dis. 51: 133\u2013134, https:\/\/doi.org\/10.1016\/j.ijid.2016.09.010.","DOI":"10.1016\/j.ijid.2016.09.010"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_108","doi-asserted-by":"crossref","unstructured":"Malaga, M., Rodriguez-Calienes, A., Marquez-Nakamatsu, A., Recuay, K., Merzthal, L., Bustamante-Paytan, D., Sifuentes, J.M., Castillo-Kohatsu, G., and Alva-Diaz, C. (2021). Predicting mechanical ventilation using the EGRIS in Guillain-Barr\u00e9 syndrome in a Latin American country. Neurocrit. Care 35: 775\u2013782, https:\/\/doi.org\/10.1007\/s12028-021-01218-z.","DOI":"10.1007\/s12028-021-01218-z"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_109","doi-asserted-by":"crossref","unstructured":"Malek, E. and Salameh, J. (2019). Guillain-Barre syndrome. Semin. Neurol. 39: 589\u2013595, https:\/\/doi.org\/10.1055\/s-0039-1693005.","DOI":"10.1055\/s-0039-1693005"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_110","doi-asserted-by":"crossref","unstructured":"Maramattom, B.V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A.A., and Mangat, H.S. (2021). Guillain-Barr\u00e9 syndrome following ChAdOx1-S\/nCoV-19 vaccine. Ann. Neurol. 90: 312\u2013314, https:\/\/doi.org\/10.1002\/ana.26143.","DOI":"10.1002\/ana.26143"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_111","doi-asserted-by":"crossref","unstructured":"M\u00e1rquez Loza, A.M., Holroyd, K.B., Johnson, S.A., Pilgrim, D.M., and Amato, A.A. (2021). Guillain-Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality. Neurology 96: 1052\u20131054, https:\/\/doi.org\/10.1212\/wnl.0000000000011881.","DOI":"10.1212\/WNL.0000000000011881"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_112","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Aguilar, L., Camps-Renom, P., Lleix\u00e0, C., Pascual-Go\u00f1i, E., D\u00edaz-Manera, J., Rojas-Garc\u00eda, R., De Luna, N., Gallardo, E., Cort\u00e9s-Vicente, E., Mu\u00f1oz, L., et al.. (2020). Serum neurofilament light chain predicts long-term prognosis in Guillain-Barr\u00e9 syndrome patients. J.\u00a0Neurol. Neurosurg. Psychiatry 92: 70\u201377, https:\/\/doi.org\/10.1136\/jnnp-2020-323899.","DOI":"10.1136\/jnnp-2020-323899"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_113","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Merino, E., Castillo-Cano, B., Mart\u00edn-Perez, M., Llorente-Garc\u00eda, A., and Montero-Corominas, D. (2021). Papillomavirus vaccination and Guillain-Barre Syndrome among girls: a cohort study in Spain. Vaccine 39: 4306\u20134313, https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.029.","DOI":"10.1016\/j.vaccine.2021.06.029"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_114","doi-asserted-by":"crossref","unstructured":"Matsui, N., Nodera, H., Kuzume, D., Iwasa, N., Unai, Y., Sakai, W., Miyazaki, Y., Yamazaki, H., Osaki, Y., Mori, A., et al.. (2018). Guillain-Barre syndrome in a local area in Japan, 2006\u20132015: an epidemiological and clinical study of 108 patients. Eur. J.\u00a0Neurol. 25: 718\u2013724, https:\/\/doi.org\/10.1111\/ene.13569.","DOI":"10.1111\/ene.13569"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_115","doi-asserted-by":"crossref","unstructured":"McGrogan, A., Madle, G.C., Seaman, H.E., and de Vries, C.S. (2009). The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review. Neuroepidemiology 32: 150\u2013163, https:\/\/doi.org\/10.1159\/000184748.","DOI":"10.1159\/000184748"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_116","doi-asserted-by":"crossref","unstructured":"Merkies, I.S. and Kieseier, B.C. (2016). Fatigue, pain, anxiety and depression in guillain-barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Eur. Neurol. 75: 199\u2013206, https:\/\/doi.org\/10.1159\/000445347.","DOI":"10.1159\/000445347"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_117","doi-asserted-by":"crossref","unstructured":"Meyer Sauteur, P.M., Huizinga, R., Tio-Gillen, A.P., Roodbol, J., Hoogenboezem, T., Jacobs, E., van Rijn, M., van der Eijk, A.A., Vink, C., de Wit, M.C., et al.. (2016). Mycoplasma pneumoniae triggering the Guillain-Barr\u00e9 syndrome: a case-control study. Ann. Neurol. 80: 566\u2013580, https:\/\/doi.org\/10.1002\/ana.24755.","DOI":"10.1002\/ana.24755"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_118","doi-asserted-by":"crossref","unstructured":"Mikami, T., Liaw, B., Asada, M., Niimura, T., Zamami, Y., Green-LaRoche, D., Pai, L., Levy, M., and Jeyapalan, S. (2021). Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database. J.\u00a0Neurooncol. 152: 135\u2013144, https:\/\/doi.org\/10.1007\/s11060-020-03687-2.","DOI":"10.1007\/s11060-020-03687-2"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_119","doi-asserted-by":"crossref","unstructured":"Milner, P., Lovelidge, C.A., Taylor, W.A., and Hughes, R.A. (1987). P0 myelin protein produces experimental allergic neuritis in Lewis rats. J.\u00a0Neurol. Sci. 79: 275\u2013285, https:\/\/doi.org\/10.1016\/0022-510x(87)90235-8.","DOI":"10.1016\/0022-510X(87)90235-8"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_120","doi-asserted-by":"crossref","unstructured":"Misawa, S., Kuwabara, S., Sato, Y., Yamaguchi, N., Nagashima, K., Katayama, K., Sekiguchi, Y., Iwai, Y., Amino, H., Suichi, T., et al.. (2018). Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol. 17: 519\u2013529, https:\/\/doi.org\/10.1016\/s1474-4422(18)30114-5.","DOI":"10.1016\/S1474-4422(18)30114-5"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_121","doi-asserted-by":"crossref","unstructured":"Mitsui, Y., Kusunoki, S., Arimura, K., Kaji, R., Kanda, T., Kuwabara, S., Sonoo, M., and Takada, K. (2015). A multicentre prospective study of Guillain-Barr\u00e9 syndrome in Japan: a focus on the incidence of subtypes. J.\u00a0Neurol. Neurosurg. Psychiatry 86: 110\u2013114, https:\/\/doi.org\/10.1136\/jnnp-2013-306509.","DOI":"10.1136\/jnnp-2013-306509"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_220","doi-asserted-by":"crossref","unstructured":"Molinero, M. R., Varon, D., Holden, K. R., Sladky, J. T., Molina, I. B., and Cleaves, F. (2003). Epidemiology of childhood Guillain-Barre syndrome as a cause of acute flaccid paralysis in Honduras: 1989-1999. J. Child Neurol. 18: 741\u2013747, https:\/\/doi.org\/10.1177\/08830738030180110801.","DOI":"10.1177\/08830738030180110801"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_224","doi-asserted-by":"crossref","unstructured":"Munayco, C. V., Soto Cabezas, M. G., Reyes, M. F., Arica Gutierrez, J. A., and Napanga Saldana, O. (2019). Epidemiology of guillain-barre syndrome in Peru. Rev. Peru. Med. Exp. Salud. Publica. 36: 10\u201316, https:\/\/doi.org\/10.17843\/rpmesp.2019.361.3729.","DOI":"10.17843\/rpmesp.2019.361.3729"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_122","doi-asserted-by":"crossref","unstructured":"Myers, T.R., McCarthy, N.L., Panagiotakopoulos, L., and Omer, S.B. (2019). Estimation of the incidence of Guillain-Barr\u00e9 syndrome during pregnancy in the United States. Open Forum Infect. Dis. 6: ofz071, https:\/\/doi.org\/10.1093\/ofid\/ofz071.","DOI":"10.1093\/ofid\/ofz071"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_123","doi-asserted-by":"crossref","unstructured":"Nachamkin, I., Arzarte Barbosa, P., Ung, H., Lobato, C., Gonzalez Rivera, A., Rodriguez, P., Garcia Briseno, A., Cordero, L.M., Garcia Perea, L., Perez, J.C., et al.. (2007). Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology 69: 1665\u20131671, https:\/\/doi.org\/10.1212\/01.wnl.0000265396.87983.bd.","DOI":"10.1212\/01.wnl.0000265396.87983.bd"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_124","doi-asserted-by":"crossref","unstructured":"Ng, Y.S., Lo, Y.L., and Lim, P.A. (2004). Characteristics and acute rehabilitation of Guillain-Barr\u00e9 syndrome in Singapore. Ann. Acad. Med. Singapore 33: 314\u2013319.","DOI":"10.47102\/annals-acadmedsg.V33N3p314"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_125","doi-asserted-by":"crossref","unstructured":"Ning, P., Yang, B., Yang, X., Zhao, Q., Huang, H., Shen, Q., Lu, H., Tian, S., and Xu, Y. (2020). A nomogram to predict mechanical ventilation in Guillain-Barr\u00e9 syndrome patients. Acta Neurol. Scand. 142: 466\u2013474, https:\/\/doi.org\/10.1111\/ane.13294.","DOI":"10.1111\/ane.13294"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_126","doi-asserted-by":"crossref","unstructured":"Ning, P., Yang, B., Yang, X., Huang, H., Shen, Q., Zhao, Q., Xie, D., Lu, H., and Xu, Y. (2021). Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barr\u00e9 syndrome. J.\u00a0Neuroimmunol. 353: 577504, https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577504.","DOI":"10.1016\/j.jneuroim.2021.577504"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_127","doi-asserted-by":"crossref","unstructured":"Ogawara, K., Kuwabara, S., Mori, M., Hattori, T., Koga, M., and Yuki, N. (2000). Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann. Neurol. 48: 624\u2013631.","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_128","doi-asserted-by":"crossref","unstructured":"Palaiodimou, L., Stefanou, M.I., Katsanos, A.H., Fragkou, P.C., Papadopoulou, M., Moschovos, C., Michopoulos, I., Kokotis, P., Bakirtzis, C., Naska, A., et al.. (2021). Prevalence, clinical characteristics and outcomes of Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: a systematic review and meta-analysis. Eur. J.\u00a0Neurol. 28: 3517\u20133529, https:\/\/doi.org\/10.1111\/ene.14860.","DOI":"10.1111\/ene.14860"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_129","doi-asserted-by":"crossref","unstructured":"Pan, P.C. and Haggiagi, A. (2019). Neurologic immune-related adverse events associated with immune checkpoint inhibition. Curr. Oncol. Rep. 21: 108, https:\/\/doi.org\/10.1007\/s11912-019-0859-2.","DOI":"10.1007\/s11912-019-0859-2"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_130","doi-asserted-by":"crossref","unstructured":"Papantoni, E., Sakorafas, G.H., Zouros, E., and Peros, G. (2010). Guillain-Barr\u0113 syndrome following total gastrectomy\/esophagectomy: a very rare and dramatic post-operative complication with a favourable outcome. ANZ J.\u00a0Surg. 80: 858, https:\/\/doi.org\/10.1111\/j.1445-2197.2010.05516.x.","DOI":"10.1111\/j.1445-2197.2010.05516.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_131","doi-asserted-by":"crossref","unstructured":"Papri, N., Islam, Z., Leonhard, S.E., Mohammad, Q.D., Endtz, H.P., and Jacobs, B.C. (2021). Guillain-Barr\u00e9 syndrome in low-income and middle-income countries: challenges and prospects. Nat. Rev. Neurol. 17: 285\u2013296, https:\/\/doi.org\/10.1038\/s41582-021-00467-y.","DOI":"10.1038\/s41582-021-00467-y"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_132","doi-asserted-by":"crossref","unstructured":"Parra, B., Lizarazo, J., Jim\u00e9nez-Arango, J.A., Zea-Vera, A.F., Gonz\u00e1lez-Manrique, G., Vargas, J., Angarita, J.A., Zu\u00f1iga, G., Lopez-Gonzalez, R., Beltran, C.L., et al.. (2016). Guillain-Barr\u00e9 syndrome associated with Zika virus infection in Colombia. N. Engl. J.\u00a0Med. 375: 1513\u20131523, https:\/\/doi.org\/10.1056\/nejmoa1605564.","DOI":"10.1056\/NEJMoa1605564"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_133","doi-asserted-by":"crossref","unstructured":"Pelea, T., Reuter, U., Schmidt, C., Laubinger, R., Siegmund, R., and Walther, B.W. (2021). SARS-CoV-2 associated Guillain-Barr\u00e9 syndrome. J.\u00a0Am. Acad. Orthop. Surg. 268: 1191\u20131194, https:\/\/doi.org\/10.1007\/s00415-020-10133-w.","DOI":"10.1007\/s00415-020-10133-w"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_134","doi-asserted-by":"crossref","unstructured":"Puertas-Mu\u00f1oz, I., Miranda-Lloret, P., Lagares, A., and Ramos-Gonz\u00e1lez, A. (2004). Guillain-Barre syndrome following resection of glioblastoma multiforme. Rev. Neurol. 39: 1137\u20131139, https:\/\/doi.org\/10.33588\/rn.3912.2004294.","DOI":"10.33588\/rn.3912.2004294"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_135","doi-asserted-by":"crossref","unstructured":"Radhakrishnan, K., el-Mangoush, M.A., and Gerryo, S.E. (1987). Descriptive epidemiology of selected neuromuscular disorders in Benghazi, Libya. Acta Neurol. Scand. 75: 95\u2013100, https:\/\/doi.org\/10.1111\/j.1600-0404.1987.tb07901.x.","DOI":"10.1111\/j.1600-0404.1987.tb07901.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_136","doi-asserted-by":"crossref","unstructured":"Rajabally, Y.A., Durand, M.C., Mitchell, J., Orlikowski, D., and Nicolas, G. (2015). Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice? J.\u00a0Neurol. Neurosurg. Psychiatry 86: 115\u2013119, https:\/\/doi.org\/10.1136\/jnnp-2014-307815.","DOI":"10.1136\/jnnp-2014-307815"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_137","doi-asserted-by":"crossref","unstructured":"Ramos, A.P., Leonhard, S.E., Halstead, S.K., Cuba, M.A., Casta\u00f1eda, C.C., Dioses, J.A., Tipismana, M.A., Abanto, J.T., Llanos, A., Gourlay, D., et al.. (2021). Guillain-Barr\u00e9 syndrome outbreak in Peru 2019 associated with Campylobacter jejuni infection. Neurol. Neuroimmunol. Neuroinflamm. 8: e952, https:\/\/doi.org\/10.1212\/nxi.0000000000000952.","DOI":"10.1212\/NXI.0000000000000952"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_138","doi-asserted-by":"crossref","unstructured":"Raschetti, R., Maggini, M., Popoli, P., Caffari, B., Da Cas, R., Menniti-Ippolito, F., Spila-Alegiani, S., and Traversa, G. (1995). Gangliosides and Guillain-Barr\u00e9 syndrome. J.\u00a0Clin. Epidemiol. 48: 1399\u20131405, https:\/\/doi.org\/10.1016\/0895-4356(95)00557-9.","DOI":"10.1016\/0895-4356(95)00557-9"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_139","doi-asserted-by":"crossref","unstructured":"Raut, M.S., Hanjoora, V.M., Chishti, M.A., and Tewari, R. (2019). Guillain-Barr\u00e9 syndrome after cardiac surgery: diagnostic dilemma. Gen. Thorac. Cardiovasc. Surg. 67: 1087\u20131088, https:\/\/doi.org\/10.1007\/s11748-018-1002-2.","DOI":"10.1007\/s11748-018-1002-2"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_140","doi-asserted-by":"crossref","unstructured":"Ravi, V., Taly, A.B., Shankar, S.K., Shenoy, P.K., Desai, A., Nagaraja, D., Gourie-Devi, M., and Chandramuki, A. (1994). Association of Japanese encephalitis virus infection with Guillain-Barr\u00e9 syndrome in endemic areas of south India. Acta Neurol. Scand. 90: 67\u201372, https:\/\/doi.org\/10.1111\/j.1600-0404.1994.tb02681.x.","DOI":"10.1111\/j.1600-0404.1994.tb02681.x"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_210","doi-asserted-by":"crossref","unstructured":"Rees, J. H., Thompson, R. D., Smeeton, N. C., and Hughes, R. A. (1998). Epidemiological study of Guillain-Barre syndrome in south east England. J. Neurol. Neurosurg. Psychiatry. 64: 74\u201377, https:\/\/doi.org\/10.1136\/jnnp.64.1.74.","DOI":"10.1136\/jnnp.64.1.74"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_141","doi-asserted-by":"crossref","unstructured":"Restrepo-Jim\u00e9nez, P., Rodr\u00edguez, Y., Gonz\u00e1lez, P., Chang, C., Gershwin, M.E., and Anaya, J.M. (2018). The immunotherapy of Guillain-Barr\u00e9 syndrome. Expet Opin. Biol. Ther. 18: 619\u2013631, https:\/\/doi.org\/10.1080\/14712598.2018.1468885.","DOI":"10.1080\/14712598.2018.1468885"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_142","doi-asserted-by":"crossref","unstructured":"Rivera-Lillo, G., Torres-Castro, R., Burgos, P.I., Varas-D\u00edaz, G., Vera-Uribe, R., Puppo, H., and Hern\u00e1ndez, M. (2016). Incidence of Guillain-Barr\u00e9 syndrome in Chile: a population-based study. J.\u00a0Peripher. Nerv. Syst. 21: 339\u2013344, https:\/\/doi.org\/10.1111\/jns.12182.","DOI":"10.1111\/jns.12182"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_143","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez, Y., Novelli, L., Rojas, M., De Santis, M., Acosta-Ampudia, Y., Monsalve, D.M., Ram\u00edrez-Santana, C., Costanzo, A., Ridgway, W.M., Ansari, A.A., et al.. (2020). Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J.\u00a0Autoimmun. 114: 102506, https:\/\/doi.org\/10.1016\/j.jaut.2020.102506.","DOI":"10.1016\/j.jaut.2020.102506"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_144","doi-asserted-by":"crossref","unstructured":"Romio, S., Weibel, D., Dieleman, J.P., Olberg, H.K., de Vries, C.S., Sammon, C., Andrews, N., Svanstr\u00f6m, H., M\u00f8lgaard-Nielsen, D., Hviid, A., et al.. (2014). Guillain-Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PLoS One 9: e82222, https:\/\/doi.org\/10.1371\/journal.pone.0082222.","DOI":"10.1371\/journal.pone.0082222"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_145","doi-asserted-by":"crossref","unstructured":"Roodbol, J., de Wit, M.C., Aarsen, F.K., Catsman-Berrevoets, C.E., and Jacobs, B.C. (2014). Long-term outcome of Guillain-Barr\u00e9 syndrome in children. J.\u00a0Peripher. Nerv. Syst. 19: 121\u2013126, https:\/\/doi.org\/10.1111\/jns5.12068.","DOI":"10.1111\/jns5.12068"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_146","doi-asserted-by":"crossref","unstructured":"Rosenblum, H.G., Hadler, S.C., Moulia, D., Shimabukuro, T.T., Su, J.R., Tepper, N.K., Ess, K.C., Woo, E.J., Mba-Jonas, A., Alimchandani, M., et al.. (2021). Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and moderna): update from the advisory committee on immunization practices\u00a0\u2013 United States, July 2021. MMWR Morb. Mortal. Wkly. Rep. 70: 1094\u20131099, https:\/\/doi.org\/10.15585\/mmwr.mm7032e4.","DOI":"10.15585\/mmwr.mm7032e4"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_147","doi-asserted-by":"crossref","unstructured":"Rudant, J., Dupont, A., Mikaeloff, Y., Bolgert, F., Coste, J., and Weill, A. (2018). Surgery and risk of Guillain-Barr\u00e9 syndrome: a French nationwide epidemiologic study. Neurology 91: e1220\u2013e1227, https:\/\/doi.org\/10.1212\/wnl.0000000000006246.","DOI":"10.1212\/WNL.0000000000006246"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_148","doi-asserted-by":"crossref","unstructured":"Ruts, L., Drenthen, J., Jongen, J.L., Hop, W.C., Visser, G.H., Jacobs, B.C., and van Doorn, P.A. (2010). Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology 75: 1439\u20131447, https:\/\/doi.org\/10.1212\/wnl.0b013e3181f88345.","DOI":"10.1212\/WNL.0b013e3181f88345"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_149","doi-asserted-by":"crossref","unstructured":"Sahai, N., Hwang, K.S., and Emami, A. (2017). Guillain-Barr\u00e9 syndrome following elective spine surgery. Eur. Spine J. 26: 6\u20138, https:\/\/doi.org\/10.1007\/s00586-016-4577-2.","DOI":"10.1007\/s00586-016-4577-2"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_150","doi-asserted-by":"crossref","unstructured":"Salinas, J.L., Major, C.G., Pastula, D.M., Dirlikov, E., Styczynski, A., Luciano, C.A., Wojna, V., Sharp, T.M., Sejvar, J.J., and Rivera-Garcia, B. (2017). Incidence and clinical characteristics of Guillain-Barr\u00e9 syndrome before the introduction of Zika virus in Puerto Rico. J.\u00a0Neurol. Sci. 377: 102\u2013106, https:\/\/doi.org\/10.1016\/j.jns.2017.04.006.","DOI":"10.1016\/j.jns.2017.04.006"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_151","doi-asserted-by":"crossref","unstructured":"Salmon, D.A., Proschan, M., Forshee, R., Gargiullo, P., Bleser, W., Burwen, D.R., Cunningham, F., Garman, P., Greene, S.K., Lee, G.M., et al.. (2013). Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 381: 1461\u20131468, https:\/\/doi.org\/10.1016\/s0140-6736(12)62189-8.","DOI":"10.1016\/S0140-6736(12)62189-8"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_152","doi-asserted-by":"crossref","unstructured":"Schonberger, L.B., Bregman, D.J., Sullivan-Bolyai, J.Z., Keenlyside, R.A., Ziegler, D.W., Retailliau, H.F., Eddins, D.L., and Bryan, J.A. (1979). Guillain-barre syndrome following vaccination in the national influenza immunization program, United States, 1976\u20131977. Am. J.\u00a0Epidemiol. 110: 105\u2013123, https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a112795.","DOI":"10.1093\/oxfordjournals.aje.a112795"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_153","doi-asserted-by":"crossref","unstructured":"Sekiguchi, Y., Mori, M., Misawa, S., Sawai, S., Yuki, N., Beppu, M., and Kuwabara, S. (2016). How often and when Fisher syndrome is overlapped by Guillain-Barr\u00e9 syndrome or Bickerstaff brainstem encephalitis? Eur. J.\u00a0Neurol. 23: 1058\u20131063, https:\/\/doi.org\/10.1111\/ene.12983.","DOI":"10.1111\/ene.12983"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_154","doi-asserted-by":"crossref","unstructured":"Shahrizaila, N., Lehmann, H.C., and Kuwabara, S. (2021). Guillain-Barr\u00e9 syndrome. Lancet 397: 1214\u20131228, https:\/\/doi.org\/10.1016\/s0140-6736(21)00517-1.","DOI":"10.1016\/S0140-6736(21)00517-1"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_155","doi-asserted-by":"crossref","unstructured":"Shakuri-Rad, J., Gavin, P.W., Todd, S.P., Tran, T.T., Christensen, C.R., Shockley, K.F., and Maatman, T.J. (2015). Guillain-Barre syndrome after robotically assisted laparoscopic prostatectomy: first case report. Urol. Case Rep. 3: 44\u201346, https:\/\/doi.org\/10.1016\/j.eucr.2015.01.004.","DOI":"10.1016\/j.eucr.2015.01.004"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_156","doi-asserted-by":"crossref","unstructured":"Shang, P., Zhu, M., Wang, Y., Zheng, X., Wu, X., Zhu, J., Feng, J., and Zhang, H.L. (2021). Axonal variants of Guillain-Barr\u00e9 syndrome: an update. J.\u00a0Am. Acad. Orthop. Surg. 268: 2402\u20132419, https:\/\/doi.org\/10.1007\/s00415-020-09742-2.","DOI":"10.1007\/s00415-020-09742-2"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_157","doi-asserted-by":"crossref","unstructured":"Sheikh, A.B., Chourasia, P.K., Javed, N., Chourasia, M.K., Suriya, S.S., Upadhyay, S., Ijaz, F., Pal, S., Moghimi, N., and Shekhar, R. (2021). Association of Guillain-Barre syndrome with COVID-19 infection: an updated systematic review. J.\u00a0Neuroimmunol. 355: 577577, https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577577.","DOI":"10.1016\/j.jneuroim.2021.577577"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_158","doi-asserted-by":"crossref","unstructured":"Shi, M., Zhu, J., and Deng, H. (2019). Clinical characteristics of intravenous injection of monosialotetrahexosyl ganglioside sodium-related guillain-Barre syndrome. Front. Neurol. 10: 225, https:\/\/doi.org\/10.3389\/fneur.2019.00225.","DOI":"10.3389\/fneur.2019.00225"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_159","doi-asserted-by":"crossref","unstructured":"Sipil\u00e4, J.O. and Soilu-H\u00e4nninen, M. (2015). The incidence and triggers of adult-onset Guillain-Barr\u00e9 syndrome in southwestern Finland 2004-2013. Eur. J.\u00a0Neurol. 22: 292\u2013298, https:\/\/doi.org\/10.1111\/ene.12565.","DOI":"10.1111\/ene.12565"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_160","doi-asserted-by":"crossref","unstructured":"Song, Y., Zhang, Y., Yuki, N., Wakerley, B.R., Liu, C., Song, J., Wang, M., Feng, X., Hao, Y., and Wang, Y. (2021). Guillain-Barr\u00e9 syndrome in Eastern China: a study of 595 patients. Eur. J.\u00a0Neurol. 28: 2727\u20132735, https:\/\/doi.org\/10.1111\/ene.14898.","DOI":"10.1111\/ene.14898"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_161","doi-asserted-by":"crossref","unstructured":"Staff, N.P., Engelstad, J., Klein, C.J., Amrami, K.K., Spinner, R.J., Dyck, P.J., Warner, M.A., Warner, M.E., and Dyck, P.J. (2010). Post-surgical inflammatory neuropathy. Brain 133: 2866\u20132880, https:\/\/doi.org\/10.1093\/brain\/awq252.","DOI":"10.1093\/brain\/awq252"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_216","doi-asserted-by":"crossref","unstructured":"Stojanov, A., Berisavac, I., Bozovic, I., Arsenijevic, M., Lukic-Rajic, S., Petrovic, M., Stojiljkovic-Tamas, O., Jovin, Z., Djordjevic, G., Jovanovic, D., et al.. (2020). Incidence and mortality rates of Guillain-Barre syndrome in Serbia. J. Peripher. Nerv. Syst. 25: 350\u2013355, https:\/\/doi.org\/10.1111\/jns.12412.","DOI":"10.1111\/jns.12412"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_162","doi-asserted-by":"crossref","unstructured":"Styczynski, A.R., Malta, JMAS, Krow-Lucal, E.R., Percio, J., N\u00f3brega, M.E., Vargas, A., Lanzieri, T.M., Leite, P.L., Staples, J.E., Fischer, M.X., et al.. (2017). Increased rates of Guillain-Barr\u00e9 syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil. PLoS Neglected Trop. Dis. 11: e0005869, https:\/\/doi.org\/10.1371\/journal.pntd.0005869.","DOI":"10.1371\/journal.pntd.0005869"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_163","doi-asserted-by":"crossref","unstructured":"Suryapranata, F.S., Ang, C.W., Chong, L.L., Murk, J.L., Falconi, J., and Huits, R.M. (2016). Epidemiology of guillain-Barre syndrome in Aruba. Am. J.\u00a0Trop. Med. Hyg. 94: 1380\u20131384, https:\/\/doi.org\/10.4269\/ajtmh.15-0070.","DOI":"10.4269\/ajtmh.15-0070"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_164","doi-asserted-by":"crossref","unstructured":"Tan, C.Y., Razali, S.N.O., Goh, K.J., and Shahrizaila, N. (2019). The utility of Guillain-Barr\u00e9 syndrome prognostic models in Malaysian patients. J.\u00a0Peripher. Nerv. Syst. 24: 168\u2013173, https:\/\/doi.org\/10.1111\/jns.12320.","DOI":"10.1111\/jns.12320"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_165","doi-asserted-by":"crossref","unstructured":"Tang, J., Dai, Y., Li, M., Cheng, M., Hong, S., Jiang, L., Cai, F., and Zhong, M. (2011). Guillain-Barr\u00e9 syndrome in Chinese children: a retrospective analysis. Pediatr. Neurol. 45: 233\u2013237, https:\/\/doi.org\/10.1016\/j.pediatrneurol.2011.06.007.","DOI":"10.1016\/j.pediatrneurol.2011.06.007"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_166","doi-asserted-by":"crossref","unstructured":"Tian, J., Cao, C., Li, T., Zhang, K., Li, P., Liu, Y., and Liu, X. (2019). Electrophysiological subtypes and prognostic factors of Guillain-Barre syndrome in northern China. Front. Neurol. 10: 714, https:\/\/doi.org\/10.3389\/fneur.2019.00714.","DOI":"10.3389\/fneur.2019.00714"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_167","doi-asserted-by":"crossref","unstructured":"Tomljenovic, L. and Shoenfeld, Y. (2013). Association between vaccination and Guillain-Barr\u00e9 syndrome. Lancet Infect. Dis. 13: 730\u2013731, https:\/\/doi.org\/10.1016\/s1473-3099(13)70142-7.","DOI":"10.1016\/S1473-3099(13)70142-7"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_168","doi-asserted-by":"crossref","unstructured":"Tsuchida, T., Saxton, R.E., Morton, D.L., and Irie, R.F. (1987). Gangliosides of human melanoma. J.\u00a0Natl. Cancer Inst. 78: 45\u201354, https:\/\/doi.org\/10.1093\/jnci\/78.1.45.","DOI":"10.1093\/jnci\/78.1.45"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_169","doi-asserted-by":"crossref","unstructured":"Ubogu, E.E., Zaidat, O.O., and Suarez, J.I. (2001). Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies. J.\u00a0Clin. Rheumatol. 7: 326\u2013331, https:\/\/doi.org\/10.1097\/00124743-200110000-00014.","DOI":"10.1097\/00124743-200110000-00014"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_170","doi-asserted-by":"crossref","unstructured":"Uncini, A., Ippoliti, L., Shahrizaila, N., Sekiguchi, Y., and Kuwabara, S. (2017). Optimizing the electrodiagnostic accuracy in Guillain-Barr\u00e9 syndrome subtypes: criteria sets and sparse linear discriminant analysis. Clin. Neurophysiol. 128: 1176\u20131183, https:\/\/doi.org\/10.1016\/j.clinph.2017.03.048.","DOI":"10.1016\/j.clinph.2017.03.048"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_171","doi-asserted-by":"crossref","unstructured":"van den Berg, B., Bunschoten, C., van Doorn, P.A., and Jacobs, B.C. (2013). Mortality in guillain-Barre syndrome. Neurology 80: 1650\u20131654, https:\/\/doi.org\/10.1212\/wnl.0b013e3182904fcc.","DOI":"10.1212\/WNL.0b013e3182904fcc"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_172","doi-asserted-by":"crossref","unstructured":"van den Berg, B., Fokke, C., Drenthen, J., van Doorn, P.A., and Jacobs, B.C. (2014a). Paraparetic Guillain-Barr\u00e9 syndrome. Neurology 82: 1984\u20131989, https:\/\/doi.org\/10.1212\/wnl.0000000000000481.","DOI":"10.1212\/WNL.0000000000000481"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_173","doi-asserted-by":"crossref","unstructured":"van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B.C., and van Doorn, P.A. (2014b). Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat. Rev. Neurol. 10: 469\u2013482, https:\/\/doi.org\/10.1038\/nrneurol.2014.121.","DOI":"10.1038\/nrneurol.2014.121"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_174","doi-asserted-by":"crossref","unstructured":"van Doorn, P.A., Ruts, L., and Jacobs, B.C. (2008). Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol. 7: 939\u2013950, https:\/\/doi.org\/10.1016\/s1474-4422(08)70215-1.","DOI":"10.1016\/S1474-4422(08)70215-1"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_175","doi-asserted-by":"crossref","unstructured":"van Koningsveld, R., Rico, R., Gerstenbluth, I., Schmitz, P.I., Ang, C.W., Merkies, I.S., Jacobs, B.C., Halabi, Y., Endtz, H.P., van der Mech\u00e9, F.G., et al.. (2001). Gastroenteritis-associated Guillain-Barr\u00e9 syndrome on the caribbean island Cura\u00e7ao. Neurology 56: 1467\u20131472, https:\/\/doi.org\/10.1212\/wnl.56.11.1467.","DOI":"10.1212\/WNL.56.11.1467"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_176","doi-asserted-by":"crossref","unstructured":"Verboon, C., van Doorn, P.A., and Jacobs, B.C. (2017). Treatment dilemmas in Guillain-Barr\u00e9 syndrome. J.\u00a0Neurol. Neurosurg. Psychiatry 88: 346\u2013352.","DOI":"10.1136\/jnnp-2016-314862"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_213","doi-asserted-by":"crossref","unstructured":"Van Koningsveld, R., Van Doorn, P. A., Schmitz, P. I., Ang, C. W., and Van der Meche, F. G. (2000). Mild forms of Guillain-Barre syndrome in an epidemiologic survey in the Netherlands. Neurology 54: 620\u2013625, https:\/\/doi.org\/10.1212\/wnl.54.3.620.","DOI":"10.1212\/WNL.54.3.620"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_177","doi-asserted-by":"crossref","unstructured":"Verboon, C., Doets, A.Y., Galassi, G., Davidson, A., Waheed, W., P\u00e9r\u00e9on, Y., Shahrizaila, N., Kusunoki, S., Lehmann, H.C., Harbo, T., et al.. (2019). Current treatment practice of Guillain-Barr\u00e9 syndrome. Neurology 93: e59\u2013e76, https:\/\/doi.org\/10.1212\/wnl.0000000000007719.","DOI":"10.1212\/WNL.0000000000007719"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_178","doi-asserted-by":"crossref","unstructured":"Wakerley, B.R. and Yuki, N. (2013). Infectious and noninfectious triggers in Guillain-Barr\u00e9 syndrome. Expet Rev. Clin. Immunol. 9: 627\u2013639, https:\/\/doi.org\/10.1586\/1744666x.2013.811119.","DOI":"10.1586\/1744666X.2013.811119"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_179","doi-asserted-by":"crossref","unstructured":"Wakerley, B.R., Uncini, A., and Yuki, N. (2014). Guillain-Barr\u00e9 and Miller Fisher syndromes--new diagnostic classification. Nat. Rev. Neurol. 10: 537\u2013544, https:\/\/doi.org\/10.1038\/nrneurol.2014.138.","DOI":"10.1038\/nrneurol.2014.138"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_180","doi-asserted-by":"crossref","unstructured":"Walgaard, C., Lingsma, H.F., Ruts, L., Drenthen, J., van Koningsveld, R., Garssen, M.J., van Doorn, P.A., Steyerberg, E.W., and Jacobs, B.C. (2010). Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome. Ann. Neurol. 67: 781\u2013787, https:\/\/doi.org\/10.1002\/ana.21976.","DOI":"10.1002\/ana.21976"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_181","doi-asserted-by":"crossref","unstructured":"Walgaard, C., Lingsma, H.F., Ruts, L., van Doorn, P.A., Steyerberg, E.W., and Jacobs, B.C. (2011). Early recognition of poor prognosis in Guillain-Barre syndrome. Neurology 76: 968\u2013975, https:\/\/doi.org\/10.1212\/wnl.0b013e3182104407.","DOI":"10.1212\/WNL.0b013e3182104407"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_182","doi-asserted-by":"crossref","unstructured":"Walgaard, C., Jacobs, B.C., Lingsma, H.F., Steyerberg, E.W., van den Berg, B., Doets, A.Y., Leonhard, S.E., Verboon, C., Huizinga, R., Drenthen, J., et al.. (2021). Second intravenous immunoglobulin dose in patients with Guillain-Barr\u00e9 syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol. 20: 275\u2013283, https:\/\/doi.org\/10.1016\/s1474-4422(20)30494-4.","DOI":"10.1016\/S1474-4422(20)30494-4"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_183","unstructured":"Wang, H., Zou, L., and Wu, H. (2011). Study on the clinical characteristics and treatment follow-up of different types of children with Guillain-Barr\u00e9 syndrome, China. J.\u00a0Am. Acad. Orthop. Surg. 49: 583\u2013588."},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_184","doi-asserted-by":"crossref","unstructured":"Wang, Y.Z., Lv, H., Shi, Q.G., Fan, X.T., Li, L., Yi Wong, A.H., Hao, Y.L., Si, C.P., Li, C.L., and Yuki, N. (2015). Action mechanism of corticosteroids to aggravate Guillain-Barr\u00e9 syndrome. Sci. Rep. 5: 13931, https:\/\/doi.org\/10.1038\/srep13931.","DOI":"10.1038\/srep13931"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_185","doi-asserted-by":"crossref","unstructured":"Wang, G., Li, H., Yang, X., Guo, T., Wang, L., Zhao, Z., Sun, H., Hou, X., Ding, X., Dou, C., et al.. (2020). Guillain-Barr\u00e9 syndrome associated with JEV infection. N. Engl. J.\u00a0Med. 383: 1188\u20131190, https:\/\/doi.org\/10.1056\/nejmc1916977.","DOI":"10.1056\/NEJMc1916977"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_186","doi-asserted-by":"crossref","unstructured":"Wanschitz, J., Maier, H., Lassmann, H., Budka, H., and Berger, T. (2003). Distinct time pattern of complement activation and cytotoxic T\u00a0cell response in Guillain-Barr\u00e9 syndrome. Brain 126: 2034\u20132042, https:\/\/doi.org\/10.1093\/brain\/awg207.","DOI":"10.1093\/brain\/awg207"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_187","doi-asserted-by":"crossref","unstructured":"Watts, P.M., Taylor, W.A., and Hughes, R.A. (1989). High-dose methylprednisolone suppresses experimental allergic neuritis in the Lewis rat. Exp. Neurol. 103: 101\u2013104, https:\/\/doi.org\/10.1016\/0014-4886(89)90191-x.","DOI":"10.1016\/0014-4886(89)90191-X"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_188","doi-asserted-by":"crossref","unstructured":"Webb, A.J., Brain, S.A., Wood, R., Rinaldi, S., and Turner, M.R. (2015). Seasonal variation in Guillain-Barr\u00e9 syndrome: a systematic review, meta-analysis and Oxfordshire cohort study. J.\u00a0Neurol. Neurosurg. Psychiatry 86: 1196\u20131201, https:\/\/doi.org\/10.1136\/jnnp-2014-309056.","DOI":"10.1136\/jnnp-2014-309056"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_189","doi-asserted-by":"crossref","unstructured":"Wen, P., Wang, L., Liu, H., Gong, L., Ji, H., Wu, H., and Chu, W. (2021). Risk factors for the severity of Guillain-Barr\u00e9 syndrome and predictors of short-term prognosis of severe Guillain-Barr\u00e9 syndrome. Sci. Rep. 11: 11578, https:\/\/doi.org\/10.1038\/s41598-021-91132-3.","DOI":"10.1038\/s41598-021-91132-3"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_190","unstructured":"Whitfield, K. and Kelly, H. (2002). Using the two-source capture-recapture method to estimate the incidence of acute flaccid paralysis in Victoria, Australia. Bull. World Health Organ. 80: 846\u2013851."},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_191","doi-asserted-by":"crossref","unstructured":"Wilgenhof, S. and Neyns, B. (2011). Anti-CTLA-4 antibody-induced Guillain-Barr\u00e9 syndrome in a melanoma patient. Ann. Oncol. 22: 991\u2013993, https:\/\/doi.org\/10.1093\/annonc\/mdr028.","DOI":"10.1093\/annonc\/mdr028"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_192","doi-asserted-by":"crossref","unstructured":"Willison, H.J., Jacobs, B.C., and van Doorn, P.A. (2016). Guillain-Barr\u00e9 syndrome. Lancet 388: 717\u2013727, https:\/\/doi.org\/10.1016\/s0140-6736(16)00339-1.","DOI":"10.1016\/S0140-6736(16)00339-1"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_193","doi-asserted-by":"crossref","unstructured":"Wu, X., Wu, W., Wang, Z., Shen, D., Pan, W., Wang, Y., Wu, L., Wu, X., Feng, J., Liu, K., et al.. (2014). More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barr\u00e9 syndrome in Northeast China. PLoS One 9: e104074, https:\/\/doi.org\/10.1016\/j.jneuroim.2014.08.130.","DOI":"10.1371\/journal.pone.0104074"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_194","doi-asserted-by":"crossref","unstructured":"Wu, X., Li, C., Zhang, B., Shen, D., Li, T., Liu, K., and Zhang, H.L. (2015). Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barr\u00e9 syndrome. Crit. Care 19: 310, https:\/\/doi.org\/10.1186\/s13054-015-1037-z.","DOI":"10.1186\/s13054-015-1037-z"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_195","doi-asserted-by":"crossref","unstructured":"Wu, X., Shen, D., Li, T., Zhang, B., Li, C., Mao, M., Zhao, J., Liu, K., and Zhang, H.L. (2016). Distinct clinical characteristics of pediatric guillain-barr\u00e9 syndrome: a comparative study between children and adults in Northeast China. PLoS One 11: e0151611, https:\/\/doi.org\/10.1371\/journal.pone.0151611.","DOI":"10.1371\/journal.pone.0151611"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_196","doi-asserted-by":"crossref","unstructured":"Xiang, J.Y., Zhang, Y.H., Tan, Z.R., Huang, J., and Zhao, Y.W. (2014). Guillain-Barr\u00e9 syndrome associated with Japanese encephalitis virus infection in China. Viral Immunol. 27: 418\u2013420.","DOI":"10.1089\/vim.2014.0049"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_197","doi-asserted-by":"crossref","unstructured":"Yamagishi, Y., Suzuki, H., Sonoo, M., Kuwabara, S., Yokota, T., Nomura, K., Chiba, A., Kaji, R., Kanda, T., Kaida, K., et al.. (2017). Markers for Guillain-Barr\u00e9 syndrome with poor prognosis: a multi-center study. J.\u00a0Peripher. Nerv. Syst. 22: 433\u2013439, https:\/\/doi.org\/10.1111\/jns.12234.","DOI":"10.1111\/jns.12234"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_198","doi-asserted-by":"crossref","unstructured":"Yoshikawa, K., Kuwahara, M., Morikawa, M., Fukumoto, Y., Yamana, M., Yamagishi, Y., and Kusunoki, S. (2018). Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases. Neurol. Neuroimmunol. Neuroinflamm. 5: e501, https:\/\/doi.org\/10.1212\/nxi.0000000000000501.","DOI":"10.1212\/NXI.0000000000000501"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_199","doi-asserted-by":"crossref","unstructured":"Yuki, N. and Hartung, H.P. (2012). Guillain-Barr\u00e9 syndrome. N. Engl. J.\u00a0Med. 366: 2294\u20132304, https:\/\/doi.org\/10.1056\/nejmra1114525.","DOI":"10.1056\/NEJMra1114525"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_200","doi-asserted-by":"crossref","unstructured":"Yuki, N., Taki, T., Takahashi, M., Saito, K., Yoshino, H., Tai, T., Handa, S., and Miyatake, T. (1994). Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher\u2019s syndrome. Ann. Neurol. 36: 791\u2013793.","DOI":"10.1002\/ana.410360517"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_201","doi-asserted-by":"crossref","unstructured":"Yuki, N., Yamada, M., Koga, M., Odaka, M., Susuki, K., Tagawa, Y., Ueda, S., Kasama, T., Ohnishi, A., Hayashi, S., et al.. (2001). Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49: 712\u2013720, https:\/\/doi.org\/10.1002\/ana.1012.","DOI":"10.1002\/ana.1012"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_202","doi-asserted-by":"crossref","unstructured":"Yuki, N., Susuki, K., Koga, M., Nishimoto, Y., Odaka, M., Hirata, K., Taguchi, K., Miyatake, T., Furukawa, K., Kobata, T., et al.. (2004). Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc. Natl. Acad. Sci. U. S. A. 101: 11404\u201311409, https:\/\/doi.org\/10.1073\/pnas.0402391101.","DOI":"10.1073\/pnas.0402391101"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_203","doi-asserted-by":"crossref","unstructured":"Zhang, M., Li, Q., He, L., Meng, F., Gu, Y., Zheng, M., Gong, Y., Wang, P., Ruan, F., Zhou, L., et al.. (2010). Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection. Foodborne Pathog. Dis. 7: 913\u2013919.","DOI":"10.1089\/fpd.2009.0493"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_204","doi-asserted-by":"crossref","unstructured":"Zhang, G., Li, Q., Zhang, R., Wei, X., Wang, J., and Qin, X. (2015). Subtypes and prognosis of guillain-barr\u00e9 syndrome in southwest China. PLoS One 10: e0133520, https:\/\/doi.org\/10.1371\/journal.pone.0133520.","DOI":"10.1371\/journal.pone.0133520"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_205","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhao, Y., and Wang, Y. (2018). Prognostic factors of Guillain-Barr\u00e9 syndrome: a 111-case retrospective review. Chin. Neurosurg. J. 4: 14, https:\/\/doi.org\/10.1186\/s41016-018-0122-y.","DOI":"10.1186\/s41016-018-0122-y"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_206","doi-asserted-by":"crossref","unstructured":"Zhao, H., Shen, D., Zhou, H., Liu, J., and Chen, S. (2020). Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 19: 383\u2013384, https:\/\/doi.org\/10.1016\/s1474-4422(20)30109-5.","DOI":"10.1016\/S1474-4422(20)30109-5"},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_207","unstructured":"Zhen, X. and Wang, X. (2012). Epidemiology analysis on reported guillain-Barr\u00e8 syndrome cases among children under 15 between 2004 and 2010 in Gansu province. Chin. Prim. Health Care 26: 66\u201367."},{"key":"2023112412354037661_j_revneuro-2023-0024_ref_208","doi-asserted-by":"crossref","unstructured":"Zhong, Y.X., Lu, G.F., Chen, X.L., and Cao, F. (2019). Postoperative Guillain-Barr\u00e9 syndrome, a neurologic complication that must not Be overlooked: a literature review. World Neurosurg. 128: 347\u2013353, https:\/\/doi.org\/10.1016\/j.wneu.2019.04.239.","DOI":"10.1016\/j.wneu.2019.04.239"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2023-0024\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2023-0024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T12:37:35Z","timestamp":1700829455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2023-0024\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":225,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,3,27]]},"published-print":{"date-parts":[[2023,12,15]]}},"alternative-id":["10.1515\/revneuro-2023-0024"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2023-0024","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]}}}